
Susanna Moore
Examiner (ID: 4754)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624 |
| Total Applications | 1838 |
| Issued Applications | 1086 |
| Pending Applications | 196 |
| Abandoned Applications | 608 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10656108
[patent_doc_number] => 20160002253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Crystalline Forms Of Pemetrexed Diacid And Processes For The Preparation Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/855818
[patent_app_country] => US
[patent_app_date] => 2015-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12026
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/855818 | Crystalline forms of pemetrexed diacid and processes for the preparation thereof | Sep 15, 2015 | Issued |
Array
(
[id] => 11949450
[patent_doc_number] => 20170253601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Substituted Pyrrolidine Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/510602
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29419
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510602 | Substituted Pyrrolidine Compounds | Sep 8, 2015 | Abandoned |
Array
(
[id] => 12680749
[patent_doc_number] => 20180118749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => P2X7 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/541040
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541040
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541040 | P2X7 MODULATORS | Aug 25, 2015 | Abandoned |
Array
(
[id] => 11979267
[patent_doc_number] => 20170283421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'SUBSTITUTED N-(PYRROLIDINE-3-YL)-7H-PYRROLO[2,3-D]PYRIMIDINE-4-AMINE AS JANUS KINASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/507409
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21823
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507409 | Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine as janus kinase inhibitor | Aug 24, 2015 | Issued |
Array
(
[id] => 11866128
[patent_doc_number] => 20170233413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/503448
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45274
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503448
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503448 | SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF | Aug 24, 2015 | Abandoned |
Array
(
[id] => 10699361
[patent_doc_number] => 20160045508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/822265
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77192
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14822265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/822265 | Pyrrolo[2,3-d]pyrimidine derivatives | Aug 9, 2015 | Issued |
Array
(
[id] => 12051158
[patent_doc_number] => 20170327503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/501233
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 54245
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501233
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501233 | Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases | Jul 30, 2015 | Issued |
Array
(
[id] => 10451950
[patent_doc_number] => 20150336964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'FUSED HETEROAROMATIC PYRROLIDINONES'
[patent_app_type] => utility
[patent_app_number] => 14/814878
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86324
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814878
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/814878 | FUSED HETEROAROMATIC PYRROLIDINONES | Jul 30, 2015 | Abandoned |
Array
(
[id] => 11963529
[patent_doc_number] => 20170267682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => '6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 15/500205
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18440
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500205
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/500205 | 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5 | Jul 29, 2015 | Issued |
Array
(
[id] => 11250332
[patent_doc_number] => 09475822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/812351
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109518
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14812351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/812351 | Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors | Jul 28, 2015 | Issued |
Array
(
[id] => 12106253
[patent_doc_number] => 09862722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-09
[patent_title] => 'Inhibitors of Bruton\'s tyrosine kinase'
[patent_app_type] => utility
[patent_app_number] => 14/811541
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62042
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811541
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811541 | Inhibitors of Bruton's tyrosine kinase | Jul 27, 2015 | Issued |
Array
(
[id] => 11834577
[patent_doc_number] => 20170216295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'CCR9 ANTAGONIST COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/501103
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9582
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15501103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/501103 | CCR9 ANTAGONIST COMPOUNDS | Jul 26, 2015 | Abandoned |
Array
(
[id] => 12172041
[patent_doc_number] => 09890168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => '2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/329183
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17851
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329183
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329183 | 2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof | Jul 23, 2015 | Issued |
Array
(
[id] => 12490323
[patent_doc_number] => 09994720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine
[patent_app_type] => utility
[patent_app_number] => 14/794860
[patent_app_country] => US
[patent_app_date] => 2015-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2702
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14794860
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/794860 | Methods for producing 1,5,7-triazabicyclo[4.4.0]dec-5-ene by reaction of a disubstituted carbodiimide and dipropylene triamine | Jul 8, 2015 | Issued |
Array
(
[id] => 10677955
[patent_doc_number] => 20160024099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'KINASE INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/793296
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 57115
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793296
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793296 | Kinase inhibitors and methods of use | Jul 6, 2015 | Issued |
Array
(
[id] => 11627231
[patent_doc_number] => 20170137421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'QUINOLIZINONE DERIVATIVES AS PI3K INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/323565
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26414
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323565
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/323565 | Quinolizinone derivatives as PI3K inhibitors | Jun 30, 2015 | Issued |
Array
(
[id] => 11619721
[patent_doc_number] => 20170129909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE'
[patent_app_type] => utility
[patent_app_number] => 15/322854
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30542
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322854
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/322854 | Spirocyclic aryl phosphorus oxide and aryl phosphorus sulfide | Jun 28, 2015 | Issued |
Array
(
[id] => 10405182
[patent_doc_number] => 20150290191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/749754
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24453
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749754 | Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors | Jun 24, 2015 | Issued |
Array
(
[id] => 10405182
[patent_doc_number] => 20150290191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/749754
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24453
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749754 | Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors | Jun 24, 2015 | Issued |
Array
(
[id] => 11669981
[patent_doc_number] => 20170158700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => '3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/320887
[patent_app_country] => US
[patent_app_date] => 2015-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94625
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320887
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320887 | 3-substituted 2-amino-indole derivatives | Jun 23, 2015 | Issued |